SCHEMBL18609700

SCHEMBL18609700

Cc1cccc(F)c1C(=O)N1CCC[C@H](C(=O)Nc2cccc(N3CCCC3)c2)C1c1ccc(N2CCCC2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.41
▸ ALDH1A1 P00352 5/20 0.41
▸ LMNA P02545 1/20 0.41
▸ TSHR P16473 3/20 0.39
▸ ALOX15 P16050 2/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ SETD2 Q9BYW2 2/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ NSD2 O96028 1/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ NPC1 O15118 2/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ USP2 O75604 3/20 0.37
▸ TP53 P04637 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12176487 1.00 MAPT (0.41) MAPTALDH1A1LMNATSHRALOX15
SCHEMBL14959078 1.00 MAPT (0.41) MAPTALDH1A1LMNATSHRALOX15
SCHEMBL12176561 1.00 MAPT (0.41) MAPTALDH1A1LMNATSHRALOX15
SCHEMBL13060135 0.95 ALDH1A1 (0.41) MAPTALDH1A1LMNATSHRALOX15
SCHEMBL12176104 0.94 ALDH1A1 (0.41) MAPTALDH1A1LMNATSHRALOX15
SCHEMBL12176586 0.94 MAPT (0.40) MAPTALDH1A1LMNATSHRALOX15
SCHEMBL12176251 0.93 SETD2 (0.38) MAPTALDH1A1LMNATSHRALOX15
SCHEMBL12176356 0.92 MAPT (0.36) MAPTALDH1A1LMNATSHRALOX15
SCHEMBL14959106 0.92 ALDH1A1 (0.38) MAPTALDH1A1LMNATSHRALOX15
SCHEMBL18790119 0.92 ALDH1A1 (0.38) MAPTALDH1A1LMNATSHRALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170065604-A1 C5aR ANTAGONISTS CHEMOCENTRYX, INC. 2017-03-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170065604-A1 C5aR ANTAGONISTS C5AR1, C5AR2, C3AR1 MAPT 4239/4885ALDH1A1 2882/4885LMNA 2758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback